Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
34
pubmed:dateCreated
1997-9-15
pubmed:abstractText
The cyclooxygenase (Cox) enzyme catalyzes the rate-limiting oxidative and peroxidative enzymatic steps in the biosynthesis of prostanoids. Both Cox-1 and -2 genes encode the two isoenzymes that carry out similar enzymatic steps. Enhanced Cox activity is associated with proliferative diseases such as colon cancer. To determine if a cause and effect relationship exists between Cox isoenzyme overexpression and tumorigenesis, the human Cox-1 and Cox-2 isoenzymes were transfected into ECV immortalized endothelial cells. Although numerous clones of Cox-1 expressing cells were obtained, Cox-2 overexpression resulted in growth disadvantage and increased cell death. In contrast, Cox-1 overexpressing cells expressed high levels of the functional Cox-1 polypeptide in the endoplasmic reticulum and the nucleus. In vitro proliferation of these cells was reduced compared with vector-transfected ECV cells. Cox-1 overexpression also enhanced the tumor necrosis factor-alpha-induced apoptosis of ECV cells 2-fold. In contrast to the in vitro behavior, ECV-Cox-1 cells proliferated aggressively and formed tumors in athymic "nude" mice, whereas the vector-transfected counterparts did not. The growth of Cox-1-induced tumors was not inhibited by indomethacin, suggesting a nonprostanoid function of Cox-1. ECV-Cox-1-derived tumors were angiosarcoma-like and contained numerous host-derived neovessels. These data suggest that Cox-1 overexpression in immortalized ECV endothelial cells results in nuclear localization of the polypeptide and tumorigenesis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
272
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21455-60
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9261162-Animals, pubmed-meshheading:9261162-Apoptosis, pubmed-meshheading:9261162-Cell Division, pubmed-meshheading:9261162-Cell Transformation, Neoplastic, pubmed-meshheading:9261162-Cyclooxygenase 1, pubmed-meshheading:9261162-Cyclooxygenase 2, pubmed-meshheading:9261162-Endothelium, Vascular, pubmed-meshheading:9261162-Humans, pubmed-meshheading:9261162-Isoenzymes, pubmed-meshheading:9261162-Membrane Proteins, pubmed-meshheading:9261162-Mice, pubmed-meshheading:9261162-Mice, Nude, pubmed-meshheading:9261162-Neoplasm Transplantation, pubmed-meshheading:9261162-Neoplasms, Experimental, pubmed-meshheading:9261162-Neovascularization, Pathologic, pubmed-meshheading:9261162-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:9261162-Transfection, pubmed-meshheading:9261162-Transplantation, Heterologous
pubmed:year
1997
pubmed:articleTitle
Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression.
pubmed:affiliation
Department of Clinical Chemistry and Obstetrics and Gynecology, Haartman Institute, Helsinki University, Helsinki, Finland.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.